Quarterly report pursuant to Section 13 or 15(d)

Organization and Basis of Presentation (Details)

v3.24.1.1.u2
Organization and Basis of Presentation (Details)
1 Months Ended 3 Months Ended
Nov. 20, 2023
USD ($)
shares
Jun. 13, 2023
USD ($)
Apr. 30, 2023
USD ($)
$ / shares
Mar. 31, 2024
USD ($)
country
Dec. 31, 2023
USD ($)
Mar. 31, 2023
USD ($)
Class of Warrant or Right [Line Items]            
Number of worldwide office locations | country       3    
Common stock, issued, net proceeds $ 26,300,000   $ 11,800,000      
Direct financing costs $ 2,500,000   $ 191,000      
Issuance of common stock and warrants, net of issuance costs (in shares) | shares 7,187,500          
Cash and cash equivalents       $ 37,301,000 $ 46,217,000 $ 19,914,000
Incremental capital (up to)       5,000,000    
Accumulated deficit       $ 151,461,000 $ 144,962,000  
Redmile            
Class of Warrant or Right [Line Items]            
Shares with rights to sell, aggregate purchase price if sold   $ 5,000,000        
Warrant One April 2023            
Class of Warrant or Right [Line Items]            
Exercise price per warrant (in dollars per share) | $ / shares     $ 0.0001